IntrinsicIntrinsic
← Scroll for more →

Financial Statements — BBIO

Balance Sheet

(in billions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Cash & Equivalents1.530.680.880.570.640.750.540.680.270.410.480.380.510.300.410.380.480.470.370.39
Short-term Investments----------0.01------0.040.040.000.000.030.030.050.080.220.260.39
Accounts Receivable0.380.250.210.140.120.080.120.00------------------------
Inventory0.060.050.030.030.020.020.00--------------------------
Total Current Assets2.041.091.240.800.840.910.700.720.440.620.780.480.590.430.550.550.640.770.720.89
Property, Plant & Equipment0.010.010.000.010.010.010.010.010.010.010.010.010.010.010.010.010.020.020.020.03
Intangible Assets0.030.030.030.030.030.030.030.020.020.030.030.030.030.030.030.030.030.030.030.04
Total Non-current Assets*0.120.120.130.140.160.170.190.200.220.180.070.070.070.070.070.070.090.090.100.12
Total Assets2.161.221.370.941.001.080.880.920.660.790.850.550.660.500.630.620.730.860.811.01
Accounts Payable0.090.030.030.040.020.030.030.010.010.020.000.010.000.000.000.010.010.010.010.01
Total Current Liabilities0.980.890.820.290.220.180.150.150.140.130.140.140.110.110.100.120.120.140.100.14
Long-term Debt2.632.652.652.012.010.000.000.440.440.440.430.450.440.440.440.43----0.430.09
Total Non-current Liabilities*2.842.832.822.722.702.682.372.221.741.741.741.751.741.741.741.751.741.741.751.74
Total Liabilities3.823.723.643.012.922.862.522.381.881.881.891.891.851.851.841.871.861.881.851.88
Retained Earnings(4.19)(4.14)(3.99)(3.82)(3.63)(3.45)(3.26)(3.10)(2.83)(2.67)(2.60)(2.56)(2.39)(2.22)(2.06)(1.92)(1.78)(1.64)(1.63)(1.44)
Total Stockholder Equity(1.66)(2.52)(2.28)(2.09)(1.93)(1.79)(1.65)(1.47)(1.23)(1.09)(1.05)(1.35)(1.21)(1.36)(1.23)(1.25)(1.14)(1.03)(1.04)(0.87)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Total Revenue353.17243.68194.52154.18120.70110.57116.635.882.732.17211.121.754.091.641.831.870.3473.751.6912.89
Cost of Revenue*20.4515.059.948.116.563.652.642.080.600.600.600.600.600.600.650.650.740.70--1.17
Gross Profit332.72228.63184.58146.07114.14106.91113.993.802.131.57210.521.153.491.041.181.22(0.40)73.05--11.34
Research & Development143.51149.45126.64116.42112.87111.23111.43130.35120.44114.70140.97130.23125.14107.4992.8690.9092.51108.40107.65122.20
Selling, General & Admin200.85186.26163.90158.09137.62129.15106.3794.7868.8259.5265.8147.5835.7836.1231.1131.8631.1936.4343.7154.75
Total Operating Expenses344.36335.71290.53285.63259.34241.19218.37229.83193.88177.11210.18178.56161.19147.14127.34130.46128.72153.22--176.95
Operating Income(11.64)(107.08)(105.96)(139.56)(145.20)(134.28)(104.37)(226.03)(191.75)(175.54)0.34(177.42)(157.69)(146.10)(126.16)(129.23)(129.12)(80.18)(173.68)(165.61)
Interest Expense------------------22.9423.4720.2720.3120.5920.1219.9919.8320.2820.3415.13
Pretax Income(59.27)(155.89)--(194.75)(186.48)(181.66)----------------------------
Tax Provision1.230.00--(0.12)(1.54)2.100.001.150.000.000.00--0.000.000.00--0.000.000.00--
Net Income(56.71)(155.89)(166.55)(194.63)(184.94)(183.76)(169.61)(267.39)(164.25)(75.54)(36.16)(170.33)(179.49)(160.70)(142.73)(140.57)(140.19)(2.56)(201.33)(152.28)
Basic EPS(0.42)(0.78)(0.84)(1.00)(0.95)(0.95)(0.88)(1.43)(0.86)(0.39)(0.20)(0.97)(1.08)(0.98)(0.92)(0.92)(0.93)(0.07)----
Diluted EPS(0.42)(0.78)(0.84)(1.00)(0.95)(0.95)(0.88)(1.43)(0.86)(0.39)(0.20)(0.97)(1.08)(0.98)(0.92)(0.92)(0.93)(0.07)----
← Scroll for more columns →

* Derived from reported values

Cash Flow Statement

(in millions USD)
MetricQ3 2026Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021
Operating Cash Flow(44.17)(71.10)(197.28)(56.42)(109.57)(80.68)(199.23)(195.33)(180.57)74.70(219.54)(124.82)(145.23)(113.35)(144.32)(93.24)(135.16)(30.45)(160.63)(133.90)
Capital Expenditures0.290.440.070.030.470.590.000.050.140.050.700.440.430.430.010.800.762.400.862.54
Free Cash Flow*(44.46)(71.54)(197.35)(56.45)(110.04)(81.28)(199.23)(195.37)(180.70)74.65(220.23)(125.25)(145.66)(113.78)(144.33)(94.04)(135.92)(32.85)(161.49)(136.43)
Investing Cash Flow36.6117.89(42.73)(14.35)4.46(13.00)(1.59)(3.24)38.233.0422.75(0.07)37.684.1212.3017.97146.86149.70138.6221.80
Financing Cash Flow863.01(148.77)549.89(2.18)(0.89)302.0460.33473.930.71(5.73)279.55(4.52)307.04(1.23)150.256.381.45(20.80)(0.16)325.38
← Scroll for more columns →

* Derived from reported values